Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metaplasia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01002443
What this trial is testing

Efficacy Study of Helicobacter Pylori Eradication in Patients Undergoing Subtotal Gastrectomy for Gastric Cancer

Who this might be right for
Gastric Cancer
National Cancer Center, Korea 190
Not applicableStudy completedNCT05969418
What this trial is testing

Deep Learning Optical Coherence Tomography (OCT) and OCT Angiography (OCTA) in NVC

Who this might be right for
Macular Degeneration Choroidal Neovascularization
Federico II University 50
Large-scale testing (Phase 3)Study completedNCT04278417
What this trial is testing

Study of Efficacy and Safety of Brolucizumab Versus Panretinal Photocoagulation Laser in Patients With Proliferative Diabetic Retinopathy

Who this might be right for
Proliferative Diabetic Retinopathy
Novartis Pharmaceuticals 689
Post-approval studies (Phase 4)Study completedNCT01628354
What this trial is testing

Study to Investigate the Safety and Efficacy of Ranibizumab in Patients With Choroidal Neovascularisation Due to Causes Other Than Age Related Macular Degeneration

Who this might be right for
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
University of Melbourne 49
Early research (Phase 1)Ended earlyNCT01868360
What this trial is testing

Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea

Who this might be right for
Corneal Neovascularization
Balamurali Ambati 2
Early research (Phase 1)Study completedNCT02204683
What this trial is testing

Pharmacokinetic Study of Intravitreal Aflibercept Injection in Eyes With Wet Age-related Macular Degeneration

Who this might be right for
Neovascular Macular Degeneration
University of Nebraska 5
Not applicableLooking for participantsNCT05700682
What this trial is testing

Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee

Who this might be right for
Osteoarthritis, KneeOsteoarthritis, HipOsteo Arthritis Shoulders+4 more
Palo Alto Veterans Institute for Research 120
Not applicableUnknownNCT04869618
What this trial is testing

Validation of an Artificial Intelligence System Based on Raman Spectroscopy for Diagnosis of Gastric Premalignant Lesions and Early Gastric Cancer

Who this might be right for
Gastric DysplasiaGastric Intestinal MetaplasiaGastric Cancer
Changi General Hospital 100
Not applicableStudy completedNCT06269380
What this trial is testing

Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy

Who this might be right for
Gastritis H PyloriGastritis ChronicIntestinal Metaplasia
Sisli Hamidiye Etfal Training and Research Hospital 671
Testing effectiveness (Phase 2)Study completedNCT03038880
What this trial is testing

Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

Who this might be right for
Neovascularization, ChoroidalMacular Degeneration, Age-Related
Hoffmann-La Roche 76
Not applicableLooking for participantsNCT06075199
What this trial is testing

Intestinal Metaplasia Cohort for Gastric Cancer Prediction

Who this might be right for
Intestinal Metaplasia of Gastric Mucosa
Seoul National University Hospital 1,000
Not applicableStudy completedNCT00919516
What this trial is testing

Autologous Bone Marrow Mononuclear Cell Implantation for Moderate to Severe Peripheral Arterial Disease

Who this might be right for
Peripheral Arterial Disease
The Vascular and Vein Center, Columbus, OH 49
Not applicableUnknownNCT05130385
What this trial is testing

High Resolution Optical Coherence Tomography

Who this might be right for
Retinal DiseaseRetinal DetachmentRetinal Vein Occlusion+13 more
Insel Gruppe AG, University Hospital Bern 550
Large-scale testing (Phase 3)Looking for participantsNCT07440225
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Testing effectiveness (Phase 2)Study completedNCT00492284
What this trial is testing

Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

Who this might be right for
Choroidal NeovascularizationMacular Degeneration
QLT Inc. 162
Testing effectiveness (Phase 2)Study completedNCT00463385
What this trial is testing

A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia

Who this might be right for
Myelofibrosis With Myeloid MetaplasiaMyeloid MetaplasiaMyelofibrosis
Celgene 88
Not applicableWithdrawnNCT03670134
What this trial is testing

Predict Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia

Who this might be right for
Barrett Esophagus
Mayo Clinic
Testing effectiveness (Phase 2)Study completedNCT00360035
What this trial is testing

Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) in the Treatment of Myelofibrosis With Myeloid Metaplasia

Who this might be right for
Myelofibrosis
Gemin X 22
Testing effectiveness (Phase 2)Study completedNCT01037348
What this trial is testing

Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

Who this might be right for
Choroidal Neovascularisation
Novartis 65
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Next Page